AP0302 5%

· Aponia Laboratories, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP0302 5%, covering 2019-02-25 to 2019-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of AP0302 5% Versus a Vehicle Comparator [Phase 2]